Jazz Pharmaceuticals (STU:J7Z) Machinery, Furniture, Equipment : €138 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Jazz Pharmaceuticals Machinery, Furniture, Equipment?

Jazz Pharmaceuticals's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2024 was €138 Mil.

Jazz Pharmaceuticals's quarterly Machinery, Furniture, Equipment increased from Sep. 2023 (€130 Mil) to Dec. 2023 (€134 Mil) and increased from Dec. 2023 (€134 Mil) to Mar. 2024 (€138 Mil).

Jazz Pharmaceuticals's annual Machinery, Furniture, Equipment increased from Dec. 2021 (€111 Mil) to Dec. 2022 (€127 Mil) and increased from Dec. 2022 (€127 Mil) to Dec. 2023 (€134 Mil).

Jazz Pharmaceuticals Machinery, Furniture, Equipment Historical Data

The historical data trend for Jazz Pharmaceuticals's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jazz Pharmaceuticals Machinery, Furniture, Equipment Chart

Jazz Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

74.04

71.18

110.95

127.06

133.61

Jazz Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															129.60	128.32	129.92	133.61	137.89

Jazz Pharmaceuticals Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Jazz Pharmaceuticals (STU:J7Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jazz Pharmaceuticals PLC (STU:J7Z) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

JAZZ:USA JAZZ:Mexico J7Z:Germany

Address

Waterloo Road, Fifth Floor, Waterloo Exchange, Dublin, IRL, D04 E5W7

Website

https://www.jazzpharmaceuticals.com

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Jazz Pharmaceuticals (STU:J7Z) Headlines

No Headlines